We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Aspen Agrees to Cut Price of Six Cancer Drugs Sharply in EU
Aspen Agrees to Cut Price of Six Cancer Drugs Sharply in EU
The European Commission said it has made legally binding an agreement by Aspen Pharma to cut prices for six cancer drugs it markets in Europe by an average of 73 percent.